{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T15:01:17Z","timestamp":1794582077537,"version":"4.9.1"},"reference-count":16,"publisher":"American Society of Hematology","issue":"20","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,10,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Myelodysplastic neoplasms (MDS) are a collection of hematopoietic disorders with widely variable prognoses and treatment options. Accurate pathologic diagnoses present challenges because of interobserver variability in interpreting morphology and quantifying dysplasia. We compared local clinical site diagnoses with central, adjudicated review from 918 participants enrolled in the ongoing National Heart, Lung, and Blood Institute National MDS Natural History Study, a prospective observational cohort study of participants with suspected MDS or MDS\/myeloproliferative neoplasms (MPNs). Locally, 264 (29%) were diagnosed as having MDS, 15 (2%) MDS\/MPN overlap, 62 (7%) idiopathic cytopenia of undetermined significance (ICUS), 0 (0%) acute myeloid leukemia (AML) with &amp;lt;30% blasts, and 577 (63%) as other. Approximately one-third of cases were reclassified after central review, with 266 (29%) diagnosed as MDS, 45 (5%) MDS\/MPN overlap, 49 (5%) ICUS, 15 (2%) AML with &amp;lt;30%, and 543 (59%) as other. Site miscoding errors accounted for more than half (53%) of the local misdiagnoses, leaving a true misdiagnosis rate of 15% overall, 21% for MDS. Therapies were reported in 37% of patients, including 43% of patients with MDS, 49% of patients with MDS\/MPN, and 86% of patients with AML with &amp;lt;30% blasts. Treatment rates were lower (25%) in cases with true discordance in diagnosis compared with those for whom local and central diagnoses agreed (40%), and receipt of inappropriate therapy occurred in 7% of misdiagnosed cases. Discordant diagnoses were frequent, which has implications for the accuracy of study-related and national registries and can lead to inappropriate therapy. This trial was registered at www.clinicaltrials.gov as #NCT05074550.<\/jats:p>","DOI":"10.1182\/bloodadvances.2023010061","type":"journal-article","created":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T13:55:14Z","timestamp":1691502914000},"page":"6120-6129","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":15,"title":["Discordant pathologic diagnoses of myelodysplastic neoplasms and their implications for registries and therapies"],"prefix":"10.1182","volume":"7","author":[{"given":"Edward J.","family":"Gorak","sequence":"first","affiliation":[{"name":"1Division of Cancer Medicine, Baptist MD Anderson Cancer Center, Jacksonville, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5489-014X","authenticated-orcid":false,"given":"Michael","family":"Otterstatter","sequence":"additional","affiliation":[{"name":"2The Emmes Corporation, Rockville, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tareq","family":"Al Baghdadi","sequence":"additional","affiliation":[{"name":"3IHA Hematology Oncology, Ypsilanti, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7744-8490","authenticated-orcid":false,"given":"Nancy","family":"Gillis","sequence":"additional","affiliation":[{"name":"4Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Foran","sequence":"additional","affiliation":[{"name":"5Department of Hematology, Mayo Clinic, Jacksonville, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane Jijun","family":"Liu","sequence":"additional","affiliation":[{"name":"6Illinois CancerCare, Peoria, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5603-4598","authenticated-orcid":false,"given":"Rafael","family":"Bejar","sequence":"additional","affiliation":[{"name":"7Moores Cancer Center, University of California San Diego, La Jolla, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven D.","family":"Gore","sequence":"additional","affiliation":[{"name":"8National Cancer Institute, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4723-6307","authenticated-orcid":false,"given":"Steven H.","family":"Kroft","sequence":"additional","affiliation":[{"name":"9Division of Hematology & Oncology, Medical College of Wisconsin, Milwaukee, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Harrington","sequence":"additional","affiliation":[{"name":"9Division of Hematology & Oncology, Medical College of Wisconsin, Milwaukee, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wael","family":"Saber","sequence":"additional","affiliation":[{"name":"9Division of Hematology & Oncology, Medical College of Wisconsin, Milwaukee, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Starczynowski","sequence":"additional","affiliation":[{"name":"10Division of Experimental Hematology and Cancer Biology, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana E.","family":"Rollison","sequence":"additional","affiliation":[{"name":"4Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1463-1458","authenticated-orcid":false,"given":"Ling","family":"Zhang","sequence":"additional","affiliation":[{"name":"4Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn","family":"Moscinski","sequence":"additional","affiliation":[{"name":"4Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffanie","family":"Wilson","sequence":"additional","affiliation":[{"name":"2The Emmes Corporation, Rockville, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Thompson","sequence":"additional","affiliation":[{"name":"2The Emmes Corporation, Rockville, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Borchert","sequence":"additional","affiliation":[{"name":"2The Emmes Corporation, Rockville, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3667-9898","authenticated-orcid":false,"given":"Seth","family":"Sherman","sequence":"additional","affiliation":[{"name":"2The Emmes Corporation, Rockville, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donnie","family":"Hebert","sequence":"additional","affiliation":[{"name":"2The Emmes Corporation, Rockville, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Ellen","family":"Walker","sequence":"additional","affiliation":[{"name":"4Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Padron","sequence":"additional","affiliation":[{"name":"4Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy E.","family":"DeZern","sequence":"additional","affiliation":[{"name":"11Sidney Kimmel Cancer Center, Johns Hopkins University, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2009-6524","authenticated-orcid":false,"given":"Mikkael A.","family":"Sekeres","sequence":"additional","affiliation":[{"name":"12Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2023,10,12]]},"reference":[{"key":"2023102319013227300_bib1","unstructured":"National Cancer Institute, Surveillance, Epidemiology, and End Results Program. Myelodysplastic syndromes (MDS) recent trends in SEER age-adjusted incidence rates, 2001-2020. 2020. Accessed 20 June 2022. https:\/\/seer.cancer.gov\/statistics-network\/explorer\/application.html?site=409&data_type=1&graph_type=2&compareBy=sex&chk_sex_1=1&chk_sex_3=3&chk_sex_2=2&hdn_rate_type=1&race=1&age_range=1&hdn_stage=101&advopt_precision=1&advopt_show_ci=on&advopt_display=2#fnote_race."},{"issue":"12","key":"2023102319013227300_bib2","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1182\/blood-2012-03-420489","article-title":"Revised International Prognostic Scoring System for myelodysplastic syndromes","volume":"120","author":"Greenberg","year":"2012","journal-title":"Blood"},{"issue":"6","key":"2023102319013227300_bib3","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1182\/blood.V89.6.2079","article-title":"International Scoring System for evaluating prognosis in myelodysplastic syndromes","volume":"89","author":"Greenberg","year":"1997","journal-title":"Blood"},{"key":"2023102319013227300_bib4","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1182\/hematology.2019000040","article-title":"Lowering the boom on lower-risk myelodysplastic syndromes","volume":"2019","author":"Sekeres","year":"2019","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"6","key":"2023102319013227300_bib5","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1182\/blood-2013-08-496935","article-title":"How we treat higher-risk myelodysplastic syndromes","volume":"123","author":"Sekeres","year":"2014","journal-title":"Blood"},{"issue":"20","key":"2023102319013227300_bib6","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"issue":"7","key":"2023102319013227300_bib7","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"issue":"26","key":"2023102319013227300_bib8","doi-asserted-by":"crossref","first-page":"7121","DOI":"10.1182\/blood-2011-02-337964","article-title":"Incidence of myelodysplastic syndromes using a novel claims-based algorithm: high number of uncaptured cases by cancer registries","volume":"117","author":"Cogle","year":"2011","journal-title":"Blood"},{"issue":"3","key":"2023102319013227300_bib9","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0002-9343(98)00032-1","article-title":"Comparison of referring and tertiary cancer center physician's diagnoses in patients with leukemia","volume":"104","author":"DeLima","year":"1998","journal-title":"Am J Med"},{"issue":"13","key":"2023102319013227300_bib10","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1080\/10428194.2019.1616186","article-title":"The National MDS Natural History Study: design of an integrated data and sample biorepository to promote research studies in myelodysplastic syndromes","volume":"60","author":"Sekeres","year":"2019","journal-title":"Leuk Lymphoma"},{"key":"2023102319013227300_bib11","author":"SAS Institute Inc","year":"2013"},{"issue":"14","key":"2023102319013227300_bib12","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.1182\/bloodadvances.2022008578","article-title":"Utility of targeted gene sequencing to differentiate myeloid malignancies from other cytopenic conditions","volume":"7","author":"DeZern","year":"2023","journal-title":"Blood Adv"},{"issue":"1","key":"2023102319013227300_bib13","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2307\/2529310","article-title":"The measurement of observer agreement for categorical data","volume":"33","author":"Landis","year":"1977","journal-title":"Biometrics"},{"issue":"3","key":"2023102319013227300_bib14","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/ptj\/85.3.257","article-title":"The Kappa statistic in reliability studies: use, interpretation, and sample size requirements","volume":"85","author":"Sim","year":"2005","journal-title":"Phys Ther"},{"issue":"11","key":"2023102319013227300_bib15","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International Consensus Classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"issue":"1","key":"2023102319013227300_bib16","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1182\/blood-2008-01-134858","article-title":"Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs","volume":"112","author":"Rollison","year":"2008","journal-title":"Blood"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/20\/6120\/2085128\/blooda_adv-2023-010061-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/20\/6120\/2085128\/blooda_adv-2023-010061-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T19:02:14Z","timestamp":1698087734000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/7\/20\/6120\/497120\/Discordant-pathologic-diagnoses-of-myelodysplastic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,12]]},"references-count":16,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2023,10,24]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2023010061","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,12]]}}}